Clinical trials
Intermittent Claudication trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Recruiting | 2 |
| Terminated | 2 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Hospital, Angers | 11 |
| Abbott Medical Devices | 1 |
| CHU de Reims | 1 |
| Hemoteq AG | 1 |
| Rennes University Hospital | 1 |
| Sanofi | 1 |
| University Hospital, Grenoble | 1 |
| University Hospital, Lille | 1 |
| University Hospital, Montpellier | 1 |
| University Hospital, Strasbourg, France | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Intermittent Claudication | 20 |
| Peripheral Arterial Disease | 13 |
| Atherosclerosis | 2 |
| Disease | 2 |
| Peripheral Vascular Diseases | 2 |
| Arteriosclerosis | 1 |
| Chronic Limb-Threatening Ischemia | 1 |
| Postthrombotic Syndrome | 1 |
| Respiration Disorders | 1 |
| Sleep Apnea Syndromes | 1 |
Trials
Showing 76 to 20 of 20. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.